List of Chapters/Sections(Table Of Content)
1 Antibody Market Overview
1.1 Product Overview and Scope of Antibody
1.2 Antibody Segment by Type
1.2.1 Global Antibody Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 IgM
1.2.3 IgG
1.2.4 IgA
1.2.5 Other
1.3 Antibody Segment by Application
1.3.1 Global Antibody Sales Comparison by Application: (2021-2027)
1.3.2 Therapeutic
1.3.3 Research
1.3.4 Diagnostic
1.4 Global Antibody Market Size Estimates and Forecasts
1.4.1 Global Antibody Revenue 2016-2027
1.4.2 Global Antibody Sales 2016-2027
1.4.3 Antibody Market Size by Region: 2016 Versus 2021 Versus 2027
2 Antibody Market Competition by Manufacturers
2.1 Global Antibody Sales Market Share by Manufacturers (2016-2021)
2.2 Global Antibody Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Antibody Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Antibody Manufacturing Sites, Area Served, Product Type
2.5 Antibody Market Competitive Situation and Trends
2.5.1 Antibody Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antibody Players Market Share by Revenue
2.5.3 Global Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antibody Retrospective Market Scenario by Region
3.1 Global Antibody Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Antibody Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Antibody Market Facts & Figures by Country
3.3.1 North America Antibody Sales by Country
3.3.2 North America Antibody Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Antibody Market Facts & Figures by Country
3.4.1 Europe Antibody Sales by Country
3.4.2 Europe Antibody Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antibody Market Facts & Figures by Region
3.5.1 Asia Pacific Antibody Sales by Region
3.5.2 Asia Pacific Antibody Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Antibody Market Facts & Figures by Country
3.6.1 Latin America Antibody Sales by Country
3.6.2 Latin America Antibody Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Antibody Market Facts & Figures by Country
3.7.1 Middle East and Africa Antibody Sales by Country
3.7.2 Middle East and Africa Antibody Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Antibody Historic Market Analysis by Type
4.1 Global Antibody Sales Market Share by Type (2016-2021)
4.2 Global Antibody Revenue Market Share by Type (2016-2021)
4.3 Global Antibody Price by Type (2016-2021)
5 Global Antibody Historic Market Analysis by Application
5.1 Global Antibody Sales Market Share by Application (2016-2021)
5.2 Global Antibody Revenue Market Share by Application (2016-2021)
5.3 Global Antibody Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Antibody Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Roche Antibody Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Johnson and Johnson
6.2.1 Johnson and Johnson Corporation Information
6.2.2 Johnson and Johnson Description and Business Overview
6.2.3 Johnson and Johnson Antibody Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Johnson and Johnson Antibody Product Portfolio
6.2.5 Johnson and Johnson Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Antibody Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck Antibody Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Antibody Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Novartis Antibody Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 AbbVie
6.5.1 AbbVie Corporation Information
6.5.2 AbbVie Description and Business Overview
6.5.3 AbbVie Antibody Sales, Revenue and Gross Margin (2016-2021)
6.5.4 AbbVie Antibody Product Portfolio
6.5.5 AbbVie Recent Developments/Updates
6.6 Amgen
6.6.1 Amgen Corporation Information
6.6.2 Amgen Description and Business Overview
6.6.3 Amgen Antibody Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Amgen Antibody Product Portfolio
6.6.5 Amgen Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Antibody Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Pfizer Antibody Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Bayer
6.8.1 Bayer Corporation Information
6.8.2 Bayer Description and Business Overview
6.8.3 Bayer Antibody Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bayer Antibody Product Portfolio
6.8.5 Bayer Recent Developments/Updates
6.9 Lilly
6.9.1 Lilly Corporation Information
6.9.2 Lilly Description and Business Overview
6.9.3 Lilly Antibody Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Lilly Antibody Product Portfolio
6.9.5 Lilly Recent Developments/Updates
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Corporation Information
6.10.2 Bristol-Myers Squibb Description and Business Overview
6.10.3 Bristol-Myers Squibb Antibody Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Bristol-Myers Squibb Antibody Product Portfolio
6.10.5 Bristol-Myers Squibb Recent Developments/Updates
6.11 GlaxoSmithKline
6.11.1 GlaxoSmithKline Corporation Information
6.11.2 GlaxoSmithKline Antibody Description and Business Overview
6.11.3 GlaxoSmithKline Antibody Sales, Revenue and Gross Margin (2016-2021)
6.11.4 GlaxoSmithKline Antibody Product Portfolio
6.11.5 GlaxoSmithKline Recent Developments/Updates
6.12 Biogen
6.12.1 Biogen Corporation Information
6.12.2 Biogen Antibody Description and Business Overview
6.12.3 Biogen Antibody Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Biogen Antibody Product Portfolio
6.12.5 Biogen Recent Developments/Updates
6.13 AstraZeneca
6.13.1 AstraZeneca Corporation Information
6.13.2 AstraZeneca Antibody Description and Business Overview
6.13.3 AstraZeneca Antibody Sales, Revenue and Gross Margin (2016-2021)
6.13.4 AstraZeneca Antibody Product Portfolio
6.13.5 AstraZeneca Recent Developments/Updates
6.14 Sanofi
6.14.1 Sanofi Corporation Information
6.14.2 Sanofi Antibody Description and Business Overview
6.14.3 Sanofi Antibody Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Sanofi Antibody Product Portfolio
6.14.5 Sanofi Recent Developments/Updates
6.15 Alexion Pharmaceuticals
6.15.1 Alexion Pharmaceuticals Corporation Information
6.15.2 Alexion Pharmaceuticals Antibody Description and Business Overview
6.15.3 Alexion Pharmaceuticals Antibody Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Alexion Pharmaceuticals Antibody Product Portfolio
6.15.5 Alexion Pharmaceuticals Recent Developments/Updates
6.16 Seattle Genetics
6.16.1 Seattle Genetics Corporation Information
6.16.2 Seattle Genetics Antibody Description and Business Overview
6.16.3 Seattle Genetics Antibody Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Seattle Genetics Antibody Product Portfolio
6.16.5 Seattle Genetics Recent Developments/Updates
7 Antibody Manufacturing Cost Analysis
7.1 Antibody Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antibody
7.4 Antibody Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antibody Distributors List
8.3 Antibody Customers
9 Antibody Market Dynamics
9.1 Antibody Industry Trends
9.2 Antibody Growth Drivers
9.3 Antibody Market Challenges
9.4 Antibody Market Restraints
10 Global Market Forecast
10.1 Antibody Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antibody by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Antibody by Type (2022-2027)
10.2 Antibody Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antibody by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Antibody by Application (2022-2027)
10.3 Antibody Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antibody by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Antibody by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
